![Ami Knoefler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ami Knoefler
Investor Relations Kontakt bei ADAGENE INC.
Aktive Positionen von Ami Knoefler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADAGENE INC. | Investor Relations Kontakt | 01.07.2021 | - |
Public Communications Contact | 01.07.2021 | - | |
Spark BioComm LLC | Gründer | - | - |
Karriereverlauf von Ami Knoefler
Ehemalige bekannte Positionen von Ami Knoefler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Abbott Biotherapeutics Corp.
![]() Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01.01.2008 | 01.05.2009 |
PDL BIOPHARMA, INC. | Public Communications Contact | 01.01.2008 | 01.01.2008 |
ASCENDIS PHARMA A/S | Direktor/Vorstandsmitglied | 01.06.2015 | 01.08.2021 |
Public Communications Contact | - | - | |
JAZZ PHARMACEUTICALS PLC | Public Communications Contact | 18.01.2012 | - |
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Investor Relations Kontakt | 01.07.2010 | - |
Public Communications Contact | 18.11.2010 | - |
Ausbildung von Ami Knoefler
Boston University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Dänemark | 2 |
Irland | 2 |
Operativ
Public Communications Contact | 5 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASCENDIS PHARMA A/S | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
ADAGENE INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Abbott Biotherapeutics Corp.
![]() Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
PDL BioPharma, Inc.
![]() PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Spark BioComm LLC |
- Börse
- Insiders
- Ami Knoefler
- Erfahrung